Brokerages expect Envision Healthcare Corp (NYSE:EVHC) to announce $2.13 billion in sales for the current fiscal quarter, according to Zacks Investment Research. Twelve analysts have issued estimates for Envision Healthcare’s earnings. The lowest sales estimate is $2.09 billion and the highest is $2.16 billion. Envision Healthcare reported sales of $1.99 billion in the same quarter last year, which indicates a positive year-over-year growth rate of 7%. The firm is scheduled to announce its next earnings results on Tuesday, October 30th.
According to Zacks, analysts expect that Envision Healthcare will report full-year sales of $8.46 billion for the current financial year, with estimates ranging from $8.39 billion to $8.53 billion. For the next fiscal year, analysts forecast that the business will post sales of $9.02 billion per share, with estimates ranging from $8.76 billion to $9.30 billion. Zacks’ sales calculations are an average based on a survey of sell-side analysts that that provide coverage for Envision Healthcare.
Envision Healthcare (NYSE:EVHC) last announced its quarterly earnings results on Monday, August 6th. The company reported $0.92 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.87 by $0.05. Envision Healthcare had a positive return on equity of 5.04% and a negative net margin of 18.81%. The company had revenue of $2.07 billion during the quarter, compared to the consensus estimate of $2.10 billion. During the same period in the previous year, the business earned $0.85 EPS. Envision Healthcare’s revenue for the quarter was up 6.5% on a year-over-year basis.
A number of analysts have recently commented on the company. Robert W. Baird cut Envision Healthcare from an “outperform” rating to a “neutral” rating in a research report on Monday, June 11th. William Blair cut Envision Healthcare from an “outperform” rating to a “market perform” rating in a research report on Monday, June 11th. Raymond James reiterated a “market perform” rating and set a $51.00 target price on shares of Envision Healthcare in a research report on Tuesday, June 12th. Cantor Fitzgerald reiterated a “hold” rating and set a $46.00 target price on shares of Envision Healthcare in a research report on Friday. Finally, Zacks Investment Research cut Envision Healthcare from a “buy” rating to a “hold” rating in a research report on Tuesday, July 10th. Two investment analysts have rated the stock with a sell rating, thirteen have given a hold rating and four have issued a buy rating to the company. The stock presently has an average rating of “Hold” and an average target price of $41.97.
Shares of EVHC traded down $0.01 during midday trading on Friday, reaching $44.67. 1,208,943 shares of the stock were exchanged, compared to its average volume of 2,035,645. The company has a debt-to-equity ratio of 0.87, a quick ratio of 2.25 and a current ratio of 2.44. Envision Healthcare has a twelve month low of $23.77 and a twelve month high of $53.26. The stock has a market capitalization of $5.41 billion, a P/E ratio of 18.01, a price-to-earnings-growth ratio of 1.14 and a beta of 0.37.
Hedge funds have recently modified their holdings of the stock. Federated Investors Inc. PA increased its position in Envision Healthcare by 194.8% in the 1st quarter. Federated Investors Inc. PA now owns 2,753 shares of the company’s stock valued at $106,000 after acquiring an additional 1,819 shares during the period. Rampart Investment Management Company LLC increased its position in Envision Healthcare by 124.4% in the 1st quarter. Rampart Investment Management Company LLC now owns 3,362 shares of the company’s stock valued at $129,000 after acquiring an additional 1,864 shares during the period. Acadian Asset Management LLC acquired a new position in Envision Healthcare in the 2nd quarter valued at about $190,000. Advisor Partners LLC acquired a new position in Envision Healthcare in the 2nd quarter valued at about $206,000. Finally, Liberty Mutual Group Asset Management Inc. acquired a new position in Envision Healthcare in the 2nd quarter valued at about $213,000.
Envision Healthcare Company Profile
Envision Healthcare Corporation, through its subsidiaries, provides various healthcare services in the United States. The company operates through two segments, Physician Services and Ambulatory Services. As of December 31, 2017, its physician-led services encompassed providers at approximately 1,800 clinical departments at healthcare facilities in 45 states and the District of Columbia that include emergency department and hospitalist, anesthesiology, radiology/tele-radiology, and children's services.
Read More: Penny Stocks
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Envision Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Envision Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.